Cigna Healthcare ranks highest in digital experience among commercial plans, while UPMC Health Plan ranks highest among Medicare Advantage plans, according to a new JD Power report. The post Which Health Plans Rank Highest In Digital Experience? appeared first on MedCity News.
By MATTHEW HOLT I know you all care, so I am giving a 7th update on the telenovela about my Labcorp bill for $34.95. The very TL:DR summary of where we are so far is that in May 2025 I had a lab test to go with the free preventative visit that the ACA guarantees, but I…
Gilead Sciences exercised its option license a Kymera Therapeutics’ protein-degrading drug designed to eliminate the cancer-driving protein CDK2. Meanwhile, Roche’s new partnership with C4 Therapeutics is focused on developing degrader antibody drug conjugates for undisclosed cancer targets. The post Gilead and Roche Bet on Protein Degraders for Their Cancer Drug Pipelines appeared first on MedCity…
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
To give patients the care they deserve and improve healthcare’s return on investment, PCPs can harness intelligent, clinically fluent AI – not to replace or override physicians or give them what tech companies think they need, but to support them in pragmatic ways. The post AI-Driven Precision Care is the Fix for Our Health System’s…
This is not a debate about care models or physician preferences. It is a contest over who will control the referral pathways and the revenue streams that originate at the front door of healthcare. The post The Quiet Battle for the Front Door of Healthcare appeared first on MedCity News.
False claims about the safety of mifepristone are driving legislative and investigative action in Congress, even as major medical organizations and decades of clinical evidence support the drug’s safety. And competing interpretations of what censorship and free speech mean are impacting how health misinformation is moderated.
[Sponsored] A new eBook explores how using real world data from patients can help drug developers improve outcomes for non-small cell lung cancer and other patient populations. The post How to Use Real-World Data to Improve Drug Development, Starting with the Patient Journey appeared first on MedCity News.
Katie Crouch says calling her state’s Medicaid agency to get information about her benefits can feel like a series of dead ends. “The first time, it’ll ring interminably. Next time, it’ll go to a voice mail that just hangs up on you,” said the 48-year-old, who lives in Delaware. “Sometimes you’ll get a person who…
Robin Carlton pays about $650 a month for a plan on the Missouri health insurance exchange that covers him and his two teenage kids. That monthly total is $200 higher than what he paid last year, due in part to the expiration in December of covid pandemic-era premium tax credits. But the self-employed St. Louis…